Major uptick reported in cannabis vaping for all adolescents

Until now time trends in vaping use had largely been unexamined including trends in use frequency, emerging disparities, and co-occurring use of other substances, which are all critical for surveillance and public health programmatic efforts. The findings are published in the journal Addiction.

"Heavy and frequent use of cannabis is increasing among U.S. adolescents, and vaped systems for products for both cannabis and nicotine are growing in number so understanding the prevalence and patterns of frequent cannabis vaping is important public health information for prevention," said Katherine Keyes, PhD, professor of epidemiology at Columbia Mailman School. "Given rising concerns about cannabis vaping in terms of safety, and potential for transition to cannabis use disorder especially at frequent levels of use, these results indicate a necessity for public health intervention and increased regulation."

The findings are based on the U.S.-based representative annual survey, Monitoring the Future, a population of 51,052 school-attending adolescents. Schools were randomly selected and invited to participate for two years.

Past 30-day frequent cannabis use with vaping increased (2.1 percent to 5.4 percent), while occasional use with vaping rose from 1.2 to 3.5 percent from 2017 to 2019. Past 30-day frequent (3.8 to 2.1 percent) and occasional (6.9 to 4.4 percent) cannabis use without vaping declined. Certain groups, such as Hispanic/Latino or lower socioeconomic status adolescents, experienced particularly notable increases in frequent cannabis use with vaping (e.g., prevalence among Hispanic/Latino adolescents in 2017: 2.2 percent, 2019: 6.7 percent)

According to Keyes, tobacco use and e-cigarettes, as well as binge drinking, are strongly linked to frequent cannabis use -- both vaping and non-vaping. The evidence indicates that young adults who use nicotine, especially through vaporizers, are more likely to subsequently use vaped cannabis.

In fact, adolescents who reported smoking and vaping nicotine on more than 10 occasions of binge drinking, were 42 times and 10 times more likely to report past 30-day cannabis use with vaping, respectively, compared to no use.

"Given that it is easier for adolescents to conceal vaping than cannabis smoking, this mode of cannabis use may facilitate more frequent use," comments Keyes.

Prevalence increased across grades, with the largest burden among high school seniors for whom past-30-day prevalence almost tripled from 5 percent (2017) to 14 percent (2019). The one-year increase in this grade from 2018 to 2019 (7.5 percent to 14 percent) is the second largest one-year increase in any type of substance use prevalence ever tracked by Monitoring the Future.

"This persisting prevalence of daily cannabis use, which in 2020 use was higher than any year since 1981, is of further alarm for several reasons, observes Keyes. "Heavy levels of cannabis use are associated with adverse cognitive and social outcomes for youth, as well as long-term trajectories of drug use that may have adverse health and other consequences."

Also concerning is that high levels of tetrahydrocannabinol (THC) can be delivered through vaping devices, which may lead to dangerous consequences for youth users with lower tolerance.

"In addition, of note, is the evidence that the increases we are seeing in vaping as compared with smoking are concentrated among non-Hispanic white and higher socioeconomic status adolescents, the latter possibly reflecting the higher price point for vaping devices compared with other administration methods, "noted Keyes.

"As cannabis legalization continues across U.S. states, and as products, delivery systems, potency and marketing proliferate within a for-profit industry, increased attention to youth trends, including investment in sustained and evidence-based prevention and intervention, is increasingly urgent."

Co-authors are Noah Kreski, Hadley Ankrum, Deborah Hasin, Silvia Martins, Mark Olfson, and Qixuan Chen, Columbia Mailman School; Magdalena Cerdá, New York University Grossman School of Medicine; and Richard Miech, University of Michigan.

The study was supported by National Center for Injury Prevention and Control, grant R49-CE003094; National Institute on Drug Abuse, grants R01DA001411, R01DA016575, R01DA037866, R01DA048853, R01DA048860.